SMPDL3B and neoplasm: Interestingly, after a 50:50 division of the Mannheim cohort into two groups by SMPDL3B expression, a lower expression of SMPDL3B in tumor samples correlated with a shorter OS (Figure 2a, p = 0.005) in long-term follow-up (average follow-up time: 168 months).